EUVIMEDOdkrijte EUVIMED
Crossref

NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m 5 C‐dependent manner

Xuan Du, Cheng Cheng, Yi Yang, Bowen Fan, Peiwen Wang, Haibo Xia, Xinye Ni, Qizhan Liu iD, Lu Lu, Lei Wei

Molecular Carcinogenesis · 2024-05 · 63 (5) · 962-976

DOI: 10.1002/mc.23701 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2024-02-27. Written by Xuan Du and 9 co-authors. Institution: Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Major MEDLINE topics: Adenocarcinoma of Lung, Lung Neoplasms, Methyltransferases. Cited 29 times so far (Crossref); 58 references. Funded by: National Natural Science Foundation of China.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

It is well known that 5‐methylcytosine (m 5 C) is involved in variety of crucial biological processes in cancers. However, its biological roles in lung adenocarcinoma (LAUD) remain to be determined. The LUAD samples were used to assess the clinical value of NOP2/Sun RNA Methyltransferase 2 (NSUN2). Dot blot was used to determine global m 5 C levels. ChIP and dual‐luciferase assays were performed to investigate the MYC‐associated zinc finger protein (MAZ)‐binding sites in NSUN2 promoter. RNA‐seq was used to explore the downstream molecular mechanisms of NSUN2. Dual luciferase reporter assay, m 5 C‐RIP‐qPCR, and mRNA stability assay were conducted to explore the effect of NSUN2‐depletion on target genes. Cell viability, transwell, and xenograft mouse model were designed to demonstrate the characteristic of NSUN2 in promoting LUAD progression. The m 5 C methyltransferase NSUN2 was highly expressed and caused elevated m 5 C methylation in LUAD samples. Mechanistically, MAZ positively regulated the transcription of NSUN2 and was related to poor survival of LUAD patients. Silencing NSUN2 decreased the global m 5 C levels, suppressed proliferation, migration and invasion, and inhibited activation of PI3K‐AKT signaling in A549 and SPAC‐1 cells. Phosphoinositide‐3‐Kinase Regulatory Subunit 2 (PIK3R2) was upregulated by NSUN2‐mediated m 5 C methylation by enhancing its mRNA stabilization and activated the phosphorylation of the PI3K‐AKT signaling. The present study explored the underlying mechanism and biological function of NSUN2‐meditated m 5 C RNA methylation in LUAD. NSUN2 was discovered to facilitate the malignancy progression of LUAD through regulating m 5 C modifications to stabilize PIK3R2 activating the PI3K‐AKT signaling, suggesting that NSUN2 could be a novel biomarker and promising therapeutic target for LUAD patients.

Subjects

MeSH terms (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsMethyltransferasesAnimalsHumansMiceCell ProliferationDisease Models, AnimalLuciferasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA Methylation5-Methylcytosine

Author keywords

5‐methylcytosine modificationAKTNSUN2PI3Klung adenocarcinoma

Substances

LuciferasesMethyltransferasesNSUN2 protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktphosphoinositol-3 kinase regulatory subunit 2, human5-Methylcytosine

Authors and institutions

  • Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Jiangsu Key Lab of Cancer Biomarkers, School of Public Health, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Suzhou Institute of Public Health, Gusu School, Center for Global Health, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Second People's Hospital of Changzhou, Nanjing Medical University, Changzhou, Jiangsu, China.
  • Animal Core facility, The Key Laboratory of Model Animal, Jiangsu Animal Experimental Center for Medical and Pharmaceutical Research, Nanjing Medical University, Nanjing, Jiangsu, China.

ORCID profiles: Qizhan Liu

Funding

  • National Natural Science Foundation of China

Cite

APA

Du, X., Cheng, C., Yang, Y., Fan, B., Wang, P., Xia, H., Ni, X., Liu, Q., Lu, L., & Wei, L. (2024). NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m 5 C‐dependent manner. Molecular Carcinogenesis, 63(5), 962-976. https://doi.org/10.1002/mc.23701

Vancouver

Du X, Cheng C, Yang Y, Fan B, Wang P, Xia H, et al. NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m 5 C‐dependent manner. Molecular Carcinogenesis. 2024;63(5):962-976. doi:10.1002/mc.23701

BibTeX
@article{Du2024,
  author = {Du, Xuan and Cheng, Cheng and Yang, Yi and Fan, Bowen and Wang, Peiwen and Xia, Haibo and Ni, Xinye and Liu, Qizhan and Lu, Lu and Wei, Lei},
  title = {NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m 5 C‐dependent manner},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  volume = {63},
  number = {5},
  pages = {962--976},
  doi = {10.1002/mc.23701}
}
Start for free →